Meridiem Investment Management’s CVS Health CVS Stock Holding History

Meridiem Investment Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,715	Closed	-$101K	–	66
2024 Q2	$101K	Hold	1,715	–	–	﹤0.01%	49
2024 Q1	$137K	Hold	1,715	–	–	﹤0.01%	51
2023 Q4	$135K	Hold	1,715	–	–	﹤0.01%	59
2023 Q3	$120K	Hold	1,715	–	–	﹤0.01%	51
2023 Q2	$119K	Sell	1,715 -335	-16%	-$23.8K	﹤0.01%	51
2023 Q1	$152K	Hold	2,050	–	–	﹤0.01%	52
2022 Q4	$191K	Hold	2,050	–	–	0.01%	48
2022 Q3	$196K	Hold	2,050	–	–	0.01%	46
2022 Q2	$190K	Sell	2,050 -495	-19%	-$48.3K	0.01%	49
2022 Q1	$258K	Hold	2,545	–	–	0.01%	46
2021 Q4	$263K	Hold	2,545	–	–	0.01%	47
2021 Q3	$216K	Hold	2,545	–	–	0.01%	50
2021 Q2	$212K	Hold	2,545	–	–	0.01%	50
2021 Q1	$191K	Hold	2,545	–	–	0.01%	52
2020 Q4	$174K	Buy	+2,545	New	+$166K	0.01%	51

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Meridiem Investment Management's CVS Position: Q3 2024 in Review

Meridiem Investment Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 1,715 shares — an estimated $101K sold.

Meridiem Investment Management first reported a position in CVS in Q4 2020 and held it in 15 quarters. The position peaked at $263K in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Meridiem Investment Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Meridiem Investment Management sold 1,715 CVS Health shares in Q3 2024, an estimated $101K.
Meridiem Investment Management first reported a position in CVS Health in Q4 2020 and held it in 15 quarters.
Meridiem Investment Management's CVS Health position peaked at $263K in Q4 2021.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Meridiem Investment Management's 13F filing for Q3 2024, filed 18 Oct 2024.